home / stock / nvo / nvo articles

NVO Articles, Novo Nordisk A/S - From 01/08/24

Stock Information
Company Name: Novo Nordisk A/S
Stock Symbol: NVO
Market: NYSE
Website: novonordisk.com
Menu
NVO NVO Quote NVO Short NVO News NVO Articles NVO Message Board
Get NVO Alerts

News, Short Squeeze, Breakout and More Instantly...
Wegovy and Ozempic Maker Novo Nordisk Shares Data From Phase 3 Diabetes Study Of Semaglutide/Insulin Containing Candidate | Benzinga

Novo Nordisk A/S (NYSE: NVO) announced topline results from the COMBINE 3 phase 3a trial of once-weekly IcoSema, a fixed-ratio combi...
Novo Nordisk's Ozempic And Wegovy Helps Lose Weight, Not One's Mind: US Study Find No Increased Suicidal Thoughts Risk | Benzinga

On Friday, a comprehensive U.S. study revealed that the use of Novo Nordisk A/S's (MYSE: NVO) drugs Ozempic and Wegovy, widely prescr...

Eli Lilly Launches Website To Help Patients With Home Delivery Options For Weight Loss Medicines | Benzinga

Drugmaker Eli Lilly And Co (NYSE:LLY) announced on Thursday a new website that allows patients to get a weight loss drug prescription through a...

Famed Obesity Drug Maker Novo Nordisk Inks Collaborations For Cardiometabolic Diseases | Benzinga

Novo Nordisk A/S (NYSE: NVO), Omega Therapeutics Inc (NASDAQ: OMGA), and Cellarity Inc. announced that Novo Nordisk has entered...
New Year Resolution Stocks: Can Getting Fitter Be A Winner On The Stock Market? | Benzinga

As another holiday season fades into memory, and we return to our desks — perhaps a little flabbier and a little hungover — will investors thin...

Novo Nordisk, Maker Of 'Miracle' Weight Loss Drug Ozempic, Announces Mega Factory In Dublin | Benzinga

Novo Nordisk A/S (NYSE:NVO), the maker of ‘Miracle‘ weight loss drugs Ozempic and Wegovy, is reportedly set to construct a large-scale ...

Fake Ozempic - FDA and Novo Nordisk Warn Against Counterfeit Ozempic Penetrating US Market Amid High Demand | Benzinga

The FDA on Thursday said it continues to investigate counterfeit Novo Nordisk A/S's (NYSE: NVO) Ozempic (semaglutide) injec...
Here's How Much $1000 Invested In Novo Nordisk 10 Years Ago Would Be Worth Today | Benzinga

Novo Nordisk (NYSE:NVO) has outperformed the market over the past 10 years by 9.16% on an annualized basis producing an average annual return of 19...

Weight Loss Drugs By Novo Nordisk, Eli Lilly Don't Deter Nestle's Coffee Demand - CEO Explains Why | Benzinga

Nestle S.A. (OTC: NSRGY) CEO Mark Schneider stated that despite the rising use of weight loss medications like Eli Lilly And Company'...

Novo Nordisk Collaborates With India's Online Marketplace To Remove Unauthorized Wegovy Listings | Benzinga

IndiaMART, an online marketplace in India, has reportedly taken action to remove unauthorized listings of Novo Nordisk A/S's (NYSE: N...
Previous 10 Next 10